TreeFrog Therapeutics

TreeFrog Therapeutics is a French-based biotech aiming to unlock access to #iPS #StemCell derived #CellTherapies for millions of patients. #CellTherapyForAll

[TreeFrog Therapeutics @treefrogtx]

CP: #ThérapiesCellulaires: @treefrogtx passe à la fabrication industrielle grâce à une nouvelle machine aux normes BPF! Next : Transfert #CDMO en 2023. Essai clinique #Parkinson en 2024. Et 3 nouveaux encapsulateurs livrés en 2023 pour accélérer! #FT120 https://t.co/xorC4E2X52

[TreeFrog Therapeutics @treefrogtx]

"Scaling-up iPSC-based cell therapies: towards clinical grade processes with biomimetic C-Stem technology"
Next Wednesday, don't miss Senior Application Scientist Odette Becheau oral presentation at the BELSACT Scientific Meeting in #Leuven.

Do not hesitate to connect with her!

[TreeFrog Therapeutics @treefrogtx]

Our #CSO Maxime Feyeux gives a snapshot of #pluripotent #stemcell #differentiation with the C-Stem™ platform.

You can check the other videos answering frequently asked questions about C-Stem™ for #iPS #expansion & #differentiation here: https://t.co/xkjZEmDV0I

[Maxime Feyeux @FeyeuxMaxime]

We get this question a lot: Can you #differentiate #pluripotent #stemcells into any cell type in C-Stem™-generated alginate capsules?
Here a quick answer. Link to our latest paper on #iPSC expansion, with some trilineage data (Fig. 3): https://t.co/wvB6NR6BzE

[Lee Buckler @celltherapy]

After the largest, longest ph 3 of any CAR-T #celltherapy, @KitePharma's
Yescarta is the 1st treatment in nearly 30 yrs to show stat significant improvement in OS for initial treatment of relapsed/refractory large B-cell lymphoma versus historical SOC. https://t.co/t2s0iRXSPa

[TreeFrog Therapeutics @treefrogtx]

@treefrogtx will be in #California next week ! Immuno-oncology Scientist Hélène CABANAS will attend the #InnateKillerSummit 2023, from March 28th to 30th.

Do not hesitate to connect with her!

#celltherapyforall

[TreeFrog Therapeutics @treefrogtx]

@treefrogtx' co-founder and CSO Maxime Feyeux will give a talk on scale-up at @JSRM_Official meeting (March 24).

Do not hesitate to connect with him on-site or during his 2-week trip through Tokyo, Kyoto, Kobe, Osaka and Fukuoka, from March 20th to April 1st.

#celltherapyforall

[John De Vos @_jdevos_]

The @treefrogtx alginate encapsulation system efficiency could be due to its ability to recapitulate in capsulo a 3D lumenized colony that morphologically resembles an epiblast rosette, and which has higher cell viability than 2D colonies.
https://t.co/5npPuffGw9

[TreeFrog Therapeutics @treefrogtx]

Following our recent paper describing #hiPSC #ScaleUp in #10L #bioreactors, our CSO highlights how the C-Stem™ platform can impact the manufacturing of stem cell-derived therapies.

More videos answering frequently asked questions about C-Stem™ : https://t.co/OAM0sAKkfy

[Maxime Feyeux @FeyeuxMaxime]

What does the C-Stem™ platform bring to the #CellTherapy field? For once I am the one answering questions in this short video about our latest paper in #Biomaterials. 5 other videos addressing FAQS about C-Stem are online: https://t.co/dRAV0bo6Yw

[TreeFrog Therapeutics @treefrogtx]

New publication demonstrating almost 300-fold #hiPSC expansion in 10L #bioreactors within 1 week with #CStem biomimetic platform with high reproducibility & preservation of cell quality.
https://t.co/Nzou4V9t45
@ISSCR @ISCTglobal @FSSCR_officiel @JSRM_Official @ESGCT @alliancerm

[STEMCELL Technologies @STEMCELLTech]

Happening live TOMORROW! ⚠️ This is your last chance to sign for this webinar on #pluripotent stem cells with Dr. Maxime Feyeux (@FeyeuxMaxime): https://t.co/AlFUg5SGgp

[TreeFrog Therapeutics @treefrogtx]

Releasing a pretty exhaustive list of cell therapy trials based on iPS & ES cells! Access for free and share!
https://t.co/YGCVYNzK5w
@pknoepfler @alliancerm @ISSCR @ISCTglobal @STEMCELLTech @nyscf @JSRM_Official @LINKJ20160324 @IPSCtherapies @ESC_iPSC_News

[STEMCELL Technologies @STEMCELLTech]

What can the human body 🧍 teach us about how to scale up high-quality #pluripotent stem cells (PSCs)?

Join us for a live webinar on March 7, with Dr. Maxime Feyeux (@FeyeuxMaxime), co-founder of TreeFrog Therapeutics (@treefrogtx), to find out. https://t.co/BaTBLkkDUR

[Alliance for Regenerative Medicine (ARM) @alliancerm]

3/6 Gaia Biomedicine & @treefrogtx announce collaboration for the expansion of allogeneic NK-like cells against solid tumors. https://t.co/0cLpgSbN2U

[TreeFrog Therapeutics @treefrogtx]

Releasing a #whitepaper on the lumenized rosette - the 3D conformation adopted by human #PluripotentStemCells in vivo !
Properties / PSC growth & quality / comparison with 2D/aggregates / Biomimetic PSC culture in large-scale bioreactors
Download : https://t.co/s8g08vzqwq

[XAnge @XAngeVC]

It's great to see some of our #startups in the new #FT120 & #Next40 rankings!

Kudos to @LeCollectionist @treefrogtx @Skelloapp @Ledger @applydia @360Learning 🤩👏

[TreeFrog Therapeutics @treefrogtx]

TreeFrog dans le #FT120 !
Quelle trajectoire ? Quels jalons à venir ? Quel impact en France ?
2 min avec Jean-Luc TREILLOU, co-fondateur de @treefrogtx.

Bienvenue aux nouveaux entrants dans le FrenchTech120, et un grand merci à @LaFrenchTech !

[TreeFrog Therapeutics @treefrogtx]

What to find on our new scientific blog ?
#1 Exclusive & free resources: a list of #CellTherapy #trials based on #Pluripotent #StemCells, a white paper on the lumenized rosette – the specific 3D conformation adopted by hPSCs in vivo, interviews... https://t.co/OAM0sAKkfy

[TreeFrog Therapeutics @treefrogtx]

@alliancerm @FierceBiotech @endpts
@statnews @PharmaScrip @FSSCR_officiel
@ISSCR @JSRM_Official @CIRMnews @iPSCellNews
@IPSCtherapies @Labiotech_eu @BioPharmaDive
@RegMedNet @LabCentral @MassBio @JSRM_Official @LINKJ20160324

[TreeFrog Therapeutics @treefrogtx]

Press Release : Clinical-stage Japanese biotech Gaia Biomedicine & TreeFrog Therapeutics announce collaboration for the expansion of allogeneic NK-like cells against solid tumors. Full press release: https://t.co/hWtnqPHuPI

[TreeFrog Therapeutics @treefrogtx]

@treefrogtx team will start 2023 in #SanFrancisco !

Frédéric Desdouits and Kévin Alessandri will attend the J.P. Morgan 41st annual Healthcare Meeting from January 9th to 12th 2023.

Feel free to reach out to schedule a meeting.

#JPMorgan #celltherapyforall

[TreeFrog Therapeutics @treefrogtx]

Meet us next week at iPSC-Derived Cell Therapies Summit, from December 6th to 7th in Boston !

Feel free to connect with our Boston team, CTO Kévin Alessandri and BD Officer Anthony Renodon, based in @LabCentral (@MassBio).

#Boston #celltherapyforall